OrthoPediatrics Files 8-K: Regulation FD & Financials
Ticker: KIDS · Form: 8-K · Filed: Aug 9, 2024 · CIK: 1425450
| Field | Detail |
|---|---|
| Company | Orthopediatrics Corp (KIDS) |
| Form Type | 8-K |
| Filed Date | Aug 9, 2024 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.00025 |
| Sentiment | neutral |
Sentiment: neutral
Topics: regulation-fd, financial-statements, filing-update
Related Tickers: KIDS
TL;DR
OrthoPediatrics (KIDS) filed an 8-K on 8/9/24 for Reg FD and financials.
AI Summary
OrthoPediatrics Corp. filed an 8-K on August 9, 2024, reporting a Regulation FD Disclosure and Financial Statements and Exhibits. The filing pertains to the company's operations as of August 8, 2024, with its principal executive offices located in Warsaw, Indiana.
Why It Matters
This filing provides important updates on OrthoPediatrics' regulatory disclosures and financial statements, which are crucial for investors to assess the company's current standing.
Risk Assessment
Risk Level: low — This is a routine filing of financial statements and regulatory disclosures, not indicating any immediate adverse events.
Key Players & Entities
- OrthoPediatrics Corp. (company) — Registrant
- KIDS (company) — Trading Symbol
- Nasdaq Global Market (company) — Exchange
- August 9, 2024 (date) — Report Date
- August 8, 2024 (date) — Earliest Event Reported
FAQ
What specific information is being disclosed under Regulation FD?
The filing indicates a Regulation FD Disclosure, but the specific details of the disclosure are not provided in the provided text snippet.
What financial statements are included in this filing?
The filing states 'Financial Statements and Exhibits' are included, but the specific financial statements are not detailed in the provided text.
When was the earliest event reported in this 8-K filing?
The earliest event reported in this filing was on August 8, 2024.
What is the trading symbol for OrthoPediatrics Corp. and on which exchange is it listed?
The trading symbol is KIDS, and it is listed on the Nasdaq Global Market.
What is the principal executive office address for OrthoPediatrics Corp.?
The principal executive offices are located at 2850 Frontier Drive, Warsaw, Indiana 46582.
Filing Stats: 505 words · 2 min read · ~2 pages · Grade level 10.4 · Accepted 2024-08-09 09:25:03
Key Financial Figures
- $0.00025 — ange on which registered Common Stock, $0.00025 par value per share KIDS Nasdaq Global
Filing Documents
- kids-20240809.htm (8-K) — 26KB
- orthopediatrics-investor.htm (EX-99.1) — 37KB
- orthopediatrics-investor001.jpg (GRAPHIC) — 70KB
- orthopediatrics-investor002.jpg (GRAPHIC) — 283KB
- orthopediatrics-investor003.jpg (GRAPHIC) — 107KB
- orthopediatrics-investor004.jpg (GRAPHIC) — 72KB
- orthopediatrics-investor005.jpg (GRAPHIC) — 73KB
- orthopediatrics-investor006.jpg (GRAPHIC) — 87KB
- orthopediatrics-investor007.jpg (GRAPHIC) — 102KB
- orthopediatrics-investor008.jpg (GRAPHIC) — 88KB
- orthopediatrics-investor009.jpg (GRAPHIC) — 107KB
- orthopediatrics-investor010.jpg (GRAPHIC) — 87KB
- orthopediatrics-investor011.jpg (GRAPHIC) — 101KB
- orthopediatrics-investor012.jpg (GRAPHIC) — 104KB
- orthopediatrics-investor013.jpg (GRAPHIC) — 95KB
- orthopediatrics-investor014.jpg (GRAPHIC) — 121KB
- orthopediatrics-investor015.jpg (GRAPHIC) — 97KB
- orthopediatrics-investor016.jpg (GRAPHIC) — 76KB
- orthopediatrics-investor017.jpg (GRAPHIC) — 123KB
- orthopediatrics-investor018.jpg (GRAPHIC) — 125KB
- orthopediatrics-investor019.jpg (GRAPHIC) — 102KB
- orthopediatrics-investor020.jpg (GRAPHIC) — 108KB
- orthopediatrics-investor021.jpg (GRAPHIC) — 116KB
- orthopediatrics-investor022.jpg (GRAPHIC) — 121KB
- orthopediatrics-investor023.jpg (GRAPHIC) — 119KB
- orthopediatrics-investor024.jpg (GRAPHIC) — 113KB
- orthopediatrics-investor025.jpg (GRAPHIC) — 71KB
- orthopediatrics-investor026.jpg (GRAPHIC) — 64KB
- orthopediatrics-investor027.jpg (GRAPHIC) — 65KB
- orthopediatrics-investor028.jpg (GRAPHIC) — 78KB
- orthopediatrics-investor029.jpg (GRAPHIC) — 81KB
- orthopediatrics-investor030.jpg (GRAPHIC) — 70KB
- orthopediatrics-investor031.jpg (GRAPHIC) — 76KB
- orthopediatrics-investor032.jpg (GRAPHIC) — 71KB
- orthopediatrics-investor033.jpg (GRAPHIC) — 87KB
- orthopediatrics-investor034.jpg (GRAPHIC) — 131KB
- orthopediatrics-investor035.jpg (GRAPHIC) — 50KB
- orthopediatrics-investor036.jpg (GRAPHIC) — 93KB
- orthopediatrics-investor037.jpg (GRAPHIC) — 33KB
- 0001425450-24-000081.txt ( ) — 5115KB
- kids-20240809.xsd (EX-101.SCH) — 2KB
- kids-20240809_lab.xml (EX-101.LAB) — 21KB
- kids-20240809_pre.xml (EX-101.PRE) — 12KB
- kids-20240809_htm.xml (XML) — 3KB
01. Regulation FD Disclosure
Item 7.01. Regulation FD Disclosure. The executive officers of OrthoPediatrics Corp. have several upcoming presentations to representatives of investors and analysts. The officers intend to use the material filed as Exhibit 99.1 herewith, in whole or in part, as part of those presentations. The information in this Item 7.01, including the information incorporated by reference herein from Exhibit 99.1, is furnished pursuant to Item 7.01 of Form 8-K and shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing.
01. Financial Statements and Exhibits
Item 9.01. Financial Statements and Exhibits. (d) Exhibits Exhibit No. Description 99.1 Orthopediatrics Corp. Investor Presentation dated August 2024 104 Cover Page Interactive Data File (embedded within the Inline XBRL document). * * * * * * SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. OrthoPediatrics Corp. Date: August 9, 2024 By: /s/ Daniel J. Gerritzen Daniel J. Gerritzen, General Counsel and Secretary - 2 -